Qi Biodesign Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 75

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $20.5M

  • Investors
  • 13

Qi Biodesign General Information

Description

Developer of genome editing technologies designed to advance plant breeding and agricultural innovation. The company offers modular genome-editing platforms, AI-based protein design, throughput transformation systems, and DNA-free editing capabilities, enabling agricultural biotechnology organizations to develop improved crop varieties with greater efficiency and precision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 302, 3rd Floor, Building 1, Number 3 Courtyard, Yingcai South First Street
  • South District, Future Science City, Beiqijia Town, Changping District
  • Beijing, Beijing 100100
  • China
+86 010
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Room 302, 3rd Floor, Building 1, Number 3 Courtyard, Yingcai South First Street
  • South District, Future Science City, Beiqijia Town, Changping District
  • Beijing, Beijing 100100
  • China
+86 010

Qi Biodesign Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qi Biodesign Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A1) 06-May-2026 $20.5M Completed Product Development
4. Early Stage VC (Series A) 02-Dec-2024 Completed Product Development
3. Early Stage VC 21-Aug-2023 Completed Product Development
2. Early Stage VC 20-Apr-2023 $14.5M $34.9M Completed Product Development
1. Seed Round 03-Dec-2021 $20.3M $20.3M Completed Startup
To view Qi Biodesign’s complete valuation and funding history, request access »

Qi Biodesign Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qi Biodesign Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
CITIC Agriculture Growth/Expansion Minority
Confitop Capital Growth/Expansion Minority
Nanjing Innovation Capital Group Venture Capital Minority
Beijing State-owned Capital Operation and Management Government Minority
Chang Development Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

Qi Biodesign FAQs

  • When was Qi Biodesign founded?

    Qi Biodesign was founded in 2021.

  • Where is Qi Biodesign headquartered?

    Qi Biodesign is headquartered in Beijing, China.

  • What is the size of Qi Biodesign?

    Qi Biodesign has 75 total employees.

  • What industry is Qi Biodesign in?

    Qi Biodesign’s primary industry is Biotechnology.

  • Is Qi Biodesign a private or public company?

    Qi Biodesign is a Private company.

  • What is Qi Biodesign’s current revenue?

    The current revenue for Qi Biodesign is .

  • How much funding has Qi Biodesign raised over time?

    Qi Biodesign has raised $110M.

  • Who are Qi Biodesign’s investors?

    CITIC Agriculture, Confitop Capital, Nanjing Innovation Capital Group, Beijing State-owned Capital Operation and Management, and Chang Development are 5 of 13 investors who have invested in Qi Biodesign.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process